$XCUR

Exicure Inc

  • NASDAQ
  • Miscellaneous Commercial Services
  • Commercial Services

PRICE

$2.18 ▲0.461%

Extented Hours

VOLUME

314,519

DAY RANGE

2.2201 - 2.5909

52 WEEK

1.49 - 43.5

Join Discuss about XCUR with like-minded investors

profile
@maletone #StockTraders.NET
recently

watchlist: $DLPN, $Xbio, $INFi, $XCUR, $apt....$FLGC if it gaps up and gets volume

60 Replies 6 👍 14 🔥

profile
@maletone #StockTraders.NET
recently

nice $XCUR had some games but got it right

61 Replies 6 👍 12 🔥

profile
@maletone #StockTraders.NET
recently

downsized on $XCUR

135 Replies 14 👍 15 🔥

profile
@maletone #StockTraders.NET
recently

just waiting on $XCUR to fail

143 Replies 7 👍 11 🔥

profile
@maletone #StockTraders.NET
recently

$XCUR so far too

71 Replies 11 👍 10 🔥

Key Metrics

Market Cap

12.26 M

Beta

1.67

Avg. Volume

1.08 M

Shares Outstanding

4.96 M

Yield

0%

Public Float

0

Next Earnings Date

2022-08-11

Next Dividend Date

Company Information

Exicure, Inc. is a clinical-stage biotechnology company developing therapeutics for immuno-oncology, inflammatory diseases and genetic disorders based on its proprietary Spherical Nucleic Acid, or SNA technology. Exicure believes its proprietary SNA architecture has distinct chemical and biological properties that may provide advantages over other nucleic acid therapeutics and may have therapeutic potential to target diseases not typically addressed with other nucleic acid therapeutics. Exicure's lead program is cavrotolimod (AST-008) which is being evaluated in a Phase1b/2 clinical trial in patients with advanced solid tumors. Exicure is based in Chicago, IL.

CEO: David Giljohann

Website:

HQ: 8045 Lamon Ave Ste 410 Skokie, 60077-5318 Illinois

Related News